Korro Bio Inc
(KRRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 0 | 0 | 9,417 | 4,651 | 9,950 |
| Gross Profit | N/A | N/A | 9,417 | 4,651 | 9,950 |
| Operating Expenses | 21,359 | 24,990 | 26,900 | 24,850 | 20,227 |
| Operating Income | -21,359 | -24,990 | -17,483 | -20,199 | -10,277 |
| Interest Expense | 182 | 182 | 182 | 218 | 0 |
| Other Income | 43 | 20 | 19 | 42 | 20 |
| Pre-tax Income | -21,498 | -25,152 | -17,646 | -20,375 | -10,257 |
| Income Tax | 2 | 3 | 10 | N/A | -25 |
| Net Income Continuous | -21,500 | -25,155 | -17,656 | -20,375 | -10,232 |
| Net Income | $-21,500 | $-25,155 | $-17,656 | $-20,375 | $-10,232 |
| EPS Basic Total Ops | -31.00 | -36.50 | -26.00 | -30.00 | -15.50 |
| EPS Basic Continuous Ops | -31.11 | -36.51 | -25.78 | -29.86 | -15.37 |
| EPS Diluted Total Ops | -31.00 | -36.50 | -26.00 | -30.00 | -15.50 |
| EPS Diluted Continuous Ops | -31.11 | -36.51 | -25.78 | -29.86 | -15.37 |
| EBITDA(a) | $-20,622 | $-24,255 | $-16,562 | $-19,817 | $-9,891 |